Global fertility research upstart acquires RADfertility
CCRM has acquired RADfertility, which has three locations in Wilmington, Newark and Dover. | PHOTO COURTESY OF FREESTOCK/UNSPLASH
NEWARK — A global upstart in fertility science and research has acquired Reproductive Associates of DE (RADfertility), a fertility center that has offices in Newark, Wilmington and Dover as part of its plans to target patients in the Mid-Atlantic region.
CCRM Fertility, a clinic offering the most advanced fertility research and treatments in the country, acquired the Delaware healthcare firm earlier this month. Terms of the acquisition were not disclosed. The brand at the Delaware facility will remain RADfertility, though CCRM officials are still working out the details of what a change might look like.
“We are just starting to partner closely with the team. We are looking at what equipment can be upgraded, where the patients are in the process and what is working and how we can build on that,” Eleanor Harte, director of operations for CCRM Fertility, told the Delaware Business Times. “From there, we’ll see where the support of a network could be most useful.”
Founded in 1987, CCRM Fertility has some of the best clinical-quality experience in in vitro fertilization (IVF) procedures, with some of the highest success rates in the industry. The company also offers advanced fertility treatments, IVF evaluations, diagnostic fertility preservation, genetic testing, egg donation, and more.
In addition, CCRM leverages its own data through the expertise of its in-house team of reproductive endocrinologists, embryologists, and geneticists.
“Our lab really started with our founder Dr. Bill Schoolcraft’s core technology in IVF, and we’re starting to explore how to automate our properties across the lab to make sure we’re delivering the best quality of care possible,” Harte said.
Over the past 35 years, CCRM has expanded to major cities in the United States, including New York, Los Angeles, Washington DC, Houston, and more. With 36 locations, the company targets 12 major metropolitan areas, including Toronto, Canada. The acquisition of the RADfertility sites now adds Delaware to that footprint, adding more options for clients in the Mid-Atlantic region.
“Our goal is to grow, but with a focus on quality and making sure we provide the best care to existing patients,” he said. “We are also seeing a greater benefit from having our sites work together. So, suppose someone hatches their eggs in New York but wants to undergo IVF treatment in Delaware, we can make that possible through our network.”
RADfertility was established in 1995 and is staffed by six board-certified reproductive endocrinologists, as well as state-of-the-art fertility care through clinical and laboratory teams. In total, the RADfertility centers will add 14 employees to the CCRM network, which has about 1,000 employees.
“We are delighted to become part of the CCRM Fertility network and continue to provide excellent fertility care services to our community,” RADFertility founder Barbara McGuirk said in a statement.
“IVF laboratory technology and advances developed by CCRM are truly the best in the world and will now be directly available to our patients,” added Ronald Feinberg. Feinberg founded and directed the RADfertility IVF program in 1997.
Both McGuirk and Feinberg will continue with the healthcare service, with McGuirk serving as director of reproductive surgery and Feinberg serving as medical director at RADfertility.
Looking ahead to the future transition, Harte said CCRM officials will continue to examine patient needs, demographics and travel times.
“We have a main center where we have surgery centers and the laboratory and clinics. We are starting to build satellite clinics to monitor database support,” she said. “To reduce the number of treatments, if someone comes to a more remote community, we will definitely evaluate our footprint.”